Skip to main content

previous disabled Page of 133
and
  1. No Access

    Article

    The Malignancy of Cancer at Different Ages: A Histological Study

    J C Lees, W W Park in British Journal of Cancer (1949)

  2. No Access

    Chapter and Conference Paper

    The Pathology of Trophoblastic Tumours

    Gestational trophoblast has at least as wide a range of pathological behaviour as any other tissue, and a wider range than most. I believe that this requires emphasis for we are in some danger of holding too n...

    W. Wallace Park in Choriocarcinoma (1967)

  3. No Access

    Book

    Experimental Lung Cancer

    Carcinogenesis and Bioassays

    Dr. Eberhard Karbe, Dr. James F. Park (1974)

  4. No Access

    Chapter

    Radiation Carcinogenesis. Introductory Remarks

    Nuclear energy is expected to provide a large fraction of the future electrical energy requirements of the world. The projected health risk of nuclear energy, compared to other electrical energy sources, is cu...

    James F. Park in Experimental Lung Cancer (1974)

  5. No Access

    Article

    Mathematical modeling of differentiation in dictyostelium discoideum

    Methods for the dynamic analysis of biochemical differentiation are presented. These are demonstrated in the analysis of biochemical differentiation of the carbohydrate system inD. discoideum. Procedures for simp...

    David J. M. Park, Barbara E. Wright in Molecular and Cellular Biochemistry (1975)

  6. No Access

    Chapter

    Biological Assumptions in the Bioassay

    The presentations made in the first session were fairly general, which led to a spectrum of comments in the discussion period. Many of the questions raised were addressed in more detail in later sessions.

    Colin Park in Carcinogenicity (1988)

  7. No Access

    Chapter and Conference Paper

    B Cell Precursors in Bone Marrow: In Vivo Proliferation, Localization, Stimulation by Activated Macrophages and Implications for Oncogenesis

    Precursor cells in mammalian bone marrow continuously give rise to virgin B lymphocytes by undergoing a series of genetic, mitotic and selection events (Osmond 1985, 1986, Osmond & Park 1987). During the diffe...

    D. G. Osmond, Y.-H. Park, K. Jacobsen in Mechanisms in B-Cell Neoplasia 1988 (1988)

  8. No Access

    Article

    Differential permeability of lymphatic and blood vessels in determining the route of metastasis as demonstrated by indirect lymphography

    Indirect mammo-lymphography with serial radiograms was made on rats bearing three established rat mammary carcinomas (SMT-2A, TMT-50, MT-W9B), with the water-soluble contrast medium, Iotasul. In the lymphogeno...

    Untae Kim, H. C. Park, K. H. Choi in Clinical & Experimental Metastasis (1988)

  9. No Access

    Article

    Current status and future aspects on treatment of liver cancer

    Among 80 patients with advanced hepatocellular carcinoma, treated by systemic chemotherapy, 19 patients (24%) achieved partial response or stable disease. The median survival time of responders was 20 weeks. R...

    Byung Soo Kim, Hyung Sik Yoo, Yong Jun Park in Cancer Chemotherapy and Pharmacology (1989)

  10. No Access

    Article

    Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings

    Radioiodinated fatty acid esters, such as lipiodol or ethiodol, are localized in the hypervascular hepatocellular carcinoma (HCC) for a long time following intra-arterial hepatic injection, enabling delivery o...

    Hyung Sik Yoo, Chan Hee Park, Jung Ho Suh in Cancer Chemotherapy and Pharmacology (1989)

  11. No Access

    Article

    Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: Effect on natural cytotoxicity

    Natural cytotoxicity (natural killer, NK, and lymphokine-activated killer, LAK, activity) was documented in 12 patients with metastatic colorectal cancer, both before and after a 5-day course of continuous the...

    K. G. M. Park, S. D. Heys, J. B. Murray, P. D. Hayes in Cancer Immunology, Immunotherapy (1992)

  12. No Access

    Chapter

    Anti-p185HER2 monoclonal antibodies: Biological properties and potential for immunotherapy

    It is by now clear that the pathogenesis of human cancer involves the aberrant functioning of the products of oncogenes. In breast and other cancers, the HER2 protooncogene appears to play an important role in...

    John W. Park, Robert Stagg, Gail D. Lewis, Paul Carter in Genes, Oncogenes, and Hormones (1992)

  13. No Access

    Article

    The human pseudoautosomal GM–CSF receptor α subunit gene is autosomal in mouse

    The gene encoding the granulocyte macrophage colony stimulating factor receptor α subunit (CSF2RA) has previously been mapped to the pseudoautosomal region of the human sex chromosomes. In contrast, we report ...

    Christine M. Disteche, Camilynn I. Brannan, Alf Larsen, David A. Adler in Nature Genetics (1992)

  14. No Access

    Article

    Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A

    Cytotoxic T lymphocytes (CTL), CD3+, α/β T-cell-receptor-positive, are important effector cells with specific immunity in melanoma patients. The establishment and expansion in vitro of CTL of a specific phenotype...

    Yoshihiko Hayashi, Dave S. B. Hoon, Min S. Park in Cancer Immunology, Immunotherapy (1992)

  15. No Access

    Article

    The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region

    This paper describes the epidemiology of AIDS-associated non-Hodgkin's lymphoma (NHL) in the World Health Organization (WHO) European Region. Data, collected by the WHO Collaborating Centre on AIDS in Paris, F...

    D Serraino, G Salamina, S Franceschi, D Dubois, C La Vecchia in British Journal of Cancer (1992)

  16. No Access

    Article

    Interleukin 2 therapy in cancer: identification of responders

    C-reactive protein (CRP) levels in serum were measured in fifteen patients with metastatic colorectal carcinoma, prior to and during treatment with a continuous intravenous infusion of rIL.2. Patients were sub...

    J Broom, SD Heys, PH Whiting, KGM Park, A Strachan, I Rothnie in British Journal of Cancer (1992)

  17. No Access

    Chapter and Conference Paper

    Oncogenic Activation of the Met/HGF Receptor Tyrosine Kinase is Promoted by Leucine Zipper Mediated Dimerization

    The met receptor tyrosine kinase is oncogenically activated by a genomic rearrangement that results in the production of a 65 kd protein containing tpr sequences fused directly to the met receptor kinase domain.

    Gerard A. Rodrigues, Morag Park in Tyrosine Phosphorylation/Dephosphorylation… (1993)

  18. No Access

    Article

    The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesothelioma

    The tumour suppressor gene WT1 encodes a transcription factor expressed in tissues of the genito–urinary system. Inactivation of this gene is associated with the development of Wilms tumour a pediatric kidney ...

    Seon Park, Martin Schalling, Amy Bernard, Shyamala Maheswaran in Nature Genetics (1993)

  19. No Access

    Article

    Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour

    Nephrogenic rests consist of foci of primitive renal cells, typically microscopic, that are found within the normal kidney tissue of children with Wilms' tumour. To study the relationship between nephrogenic r...

    Seon Park, Amy Bernard, Kevin E. Bove, Donald A. Sens in Nature Genetics (1993)

  20. No Access

    Article

    Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol

    The aim of the present study was to deliver a high internal radiation dose to small hepatocellular carcinoma (HCC) lesions in an attempt to treat this disease. A total of 18 patients with HCC lesions measuring...

    Hyung Sik Yoo, Chan Hee Park, Jong Tae Lee in Cancer Chemotherapy and Pharmacology (1994)

previous disabled Page of 133